Steris SEC filings, summarized
We read every Steris 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track STE in your inbox
Add Steris to your watchlist — free, every morning.
Recent filings
STERIS to consolidate chemistry operations in North Carolina with $55M-$70M in charges
STERIS announced on August 5, 2026, that it will consolidate formulated-chemistry manufacturing and distribution at a new North Carolina Center of…
STERIS reports 7% revenue growth and raises fiscal 2027 capital spending
STERIS reported fiscal 2027 first-quarter revenue of $1.5 billion for the quarter ended June 30, 2026, up 7% year over year, while diluted EPS rose to $2.04…
STERIS ($STE) filed an 8‑K on Feb 4, 2026 to furnish a press release announcing fiscal 2026 Q3 results for…
STERIS ($STE) filed an 8‑K on Feb 4, 2026 to furnish a press release announcing fiscal 2026 Q3 results for the period ended Dec 31, 2025. 📢 #STERIS…
STERIS ($STE) on Feb 4, 2026 issued a press release with financial results for the quarter ended Dec 31, 2025.
STERIS ($STE) on Feb 4, 2026 issued a press release with financial results for the quarter ended Dec 31, 2025. The release is attached to the 8‑K as Exhibit…